Nyxoah SA Revenue 2021-2024 | NYXH
Nyxoah SA revenue from 2021 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Nyxoah SA Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $5 |
| 2022 | $3 |
| 2021 | $1 |
| 2020 | $0 |
| Nyxoah SA Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-06-30 | $1 |
| 2024-03-31 | $1 |
| 2023-12-31 | $2 |
| 2023-09-30 | $1 |
| 2023-06-30 | $1 |
| 2023-03-31 | $0 |
| 2022-12-31 | $1 |
| 2022-09-30 | $0 |
| 2022-06-30 | $1 |
| 2022-03-31 | $1 |
| 2021-12-31 | |
| 2021-06-30 | |
| 2021-03-31 | $0 |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.000B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $41.383B | 22.26 |
| Tempus AI (TEM) | United States | $7.730B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $6.325B | 1178.33 |
| Hims & Hers Health (HIMS) | United States | $3.634B | 211.50 |
| Axonics (AXNX) | United States | $3.540B | 0.00 |
| 10x Genomics (TXG) | United States | $2.829B | 0.00 |
| Enovis (ENOV) | United States | $2.514B | 18.23 |
| Azenta (AZTA) | United States | $2.421B | 137.50 |
| Privia Health (PRVA) | United States | $2.324B | 162.00 |
| IRhythm Technologies (IRTC) | United States | $2.283B | 0.00 |
| Omnicell (OMCL) | United States | $1.997B | 65.79 |
| Schrodinger (SDGR) | United States | $1.517B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.507B | 0.00 |
| Phreesia (PHR) | United States | $1.373B | 0.00 |
| Standard BioTools (LAB) | United States | $0.783B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.693B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.567B | 481.00 |
| Health Catalyst (HCAT) | United States | $0.534B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.408B | 0.00 |
| Talkspace (TALK) | United States | $0.353B | 0.00 |
| Pulmonx (LUNG) | United States | $0.336B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.277B | 0.00 |
| TruBridge (TBRG) | United States | $0.184B | 13.49 |
| P3 Health Partners (PIII) | United States | $0.160B | 0.00 |
| American Well (AMWL) | United States | $0.149B | 0.00 |
| Augmedix (AUGX) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.084B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.056B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.054B | 0.00 |
| 111 (YI) | China | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.049B | 0.00 |
| CareCloud (CCLD) | United States | $0.047B | 0.00 |
| Movano (MOVE) | United States | $0.036B | 0.00 |
| Outset Medical (OM) | United States | $0.031B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.024B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.019B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.018B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Syra Health (SYRA) | United States | $0.003B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |